financetom
Business
financetom
/
Business
/
Pony AI Q4 Adjusted Loss Narrows, Revenue Falls; Shares Up Pre-Bell
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pony AI Q4 Adjusted Loss Narrows, Revenue Falls; Shares Up Pre-Bell
Mar 26, 2026 2:50 AM

05:41 AM EDT, 03/26/2026 (MT Newswires) -- Pony AI (PONY) reported a Q4 non-GAAP net loss Thursday of $0.12 per diluted share, versus a $0.23 loss a year earlier.

A single analyst polled by FactSet expected a $0.15 loss.

Revenue for the quarter that ended Dec. 31 was $29.1 million, down from $35.5 million a year earlier.

Two analysts surveyed by FactSet expected $27.2 million.

The company's shares were up 2.3% in premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Chile investigators head to NZ for LATAM Boeing 787 probe, aviation body says
Chile investigators head to NZ for LATAM Boeing 787 probe, aviation body says
Mar 12, 2024
SANTIAGO, March 12 (Reuters) - Investigators from Chile's aviation authority are traveling to New Zealand on Tuesday to investigate an incident involving a LATAM Airlines Boeing plane which left more than 50 people injured. Chile's DGAC aviation body said in a statement it will take the lead on the investigation after the plane, carrying 263 passengers and nine crew members,...
Nike Likely to Deliver EPS Beat in Fiscal Q3, Morgan Stanley Says
Nike Likely to Deliver EPS Beat in Fiscal Q3, Morgan Stanley Says
Mar 12, 2024
12:42 PM EDT, 03/12/2024 (MT Newswires) -- Nike's ( NKE ) fiscal Q3 EPS could top market expectations when it releases its results March 21, with outperforming gross margin driving the upside, Morgan Stanley said in a Tuesday note. The investment firm said it also expects Nike's ( NKE ) gross margin to outperform in fiscal Q4 as it models...
Cadrenal Therapeutics Files $100 Million Mixed Shelf; Shares Fall
Cadrenal Therapeutics Files $100 Million Mixed Shelf; Shares Fall
Mar 12, 2024
12:42 PM EDT, 03/12/2024 (MT Newswires) -- Cadrenal Therapeutics ( CVKD ) on Tuesday filed a registration statement for the potential sale of up to $100 million of its securities from time to time. The filing covers the potential sale of common stock, preferred stock, debt securities, warrants and units. Unless otherwise stated in a prospectus supplement, the company said...
FibroGen Shares Jump After CEO Stock Purchase
FibroGen Shares Jump After CEO Stock Purchase
Mar 12, 2024
12:42 PM EDT, 03/12/2024 (MT Newswires) -- FibroGen ( FGEN ) shares climbed 13% in recent Tuesday trading after Chief Executive Officer Thane Wettig recently bought 50,000 of the company's common shares at $1.9094 each. Wettig has control over 471,178 shares with all except 1,000 held directly, according to a regulatory filing. Price: 1.93, Change: +0.22, Percent Change: +12.87 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved